Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Occam's Razor and the Diagnosis of Mantle Cell Lymphoma.

Lui JK, Gillespie W, Gaudet R, Brettler DB.

Am J Med. 2015 Dec;128(12):e25-6. doi: 10.1016/j.amjmed.2015.06.050. Epub 2015 Jul 30. No abstract available.

PMID:
26235247
2.

Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.

Boylan B, Rice AS, Dunn AL, Tarantino MD, Brettler DB, Barrett JC, Miller CH; Hemophilia Inhibitor Research Study Investigators; Hemophilia Inhibitor Research Study Investigators.

J Thromb Haemost. 2015 Jan;13(1):47-53. doi: 10.1111/jth.12768. Epub 2014 Dec 11.

3.

Gene therapy for hemophilia?

Brettler DB.

J Thromb Haemost. 2005 Jun;3(6):1317-9. No abstract available.

4.

The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.

Engelfriet CP, Reesink HW, Mannucci PM, Gringeri A, Ingerslev J, Brettler DB, Mauser-Bunschoten EP, Negrier C, Berntorp E, Smith OP, Shapiro AD.

Vox Sang. 2000;78(4):256-61. No abstract available.

PMID:
10970234
5.

Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort.

Greenough TC, Brettler DB, Kirchhoff F, Alexander L, Desrosiers RC, O'Brien SJ, Somasundaran M, Luzuriaga K, Sullivan JL.

J Infect Dis. 1999 Dec;180(6):1790-802.

PMID:
10558933
6.

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo.

Greenough TC, Brettler DB, Somasundaran M, Panicali DL, Sullivan JL.

J Infect Dis. 1997 Jul;176(1):118-25.

PMID:
9207357
7.

A recombinant circumsporozoite protein vaccine against malaria.

Brettler DB.

N Engl J Med. 1997 Jun 12;336(24):1759; author reply 1760-1. No abstract available.

PMID:
9182221
8.

DDI and liver tests in HIV-1 seropositive haemophiliacs.

Shopnick RI, Brettler DB, Forand P, McDONALD M.

Haemophilia. 1997 Jan;3(1):35-8. doi: 10.1046/j.1365-2516.1997.00056.x.

PMID:
27214617
9.

AIDS-associated non-Hodgkin's lymphomas as primary and secondary AIDS diagnoses in hemophiliacs. Hemophilia Malignancy Study Group.

Ragni MV, Belle SH, Jaffe R, Locker J, Duerstein SL, Bass DC, Addiego JE, Aledort LM, Barron LE, Brettler DB, Buchanan GR, Gill JC, Ewenstein BM, Green D, Hilgartner MW, Hoots WK, Kisker CT, Lovrien EW, Rutherford CJ, Sanders NL, Smith KJ, Stabler SP, Swindells S, White GC 3rd, Kingsley LA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Sep;13(1):78-86.

PMID:
8797689
10.

Hemostasis: a practical review of conservative and operative care.

Shopnick RI, Brettler DB.

Clin Orthop Relat Res. 1996 Jul;(328):34-8. Review.

PMID:
8653974
11.

Inhibitors in congenital haemophilia.

Brettler DB.

Baillieres Clin Haematol. 1996 Jun;9(2):319-29. Review.

PMID:
8800508
12.

Hepatitis C seropositivity in HIV-negative children with severe haemophilia.

Shopnick RI, Bolivar E, Brettler DB.

Haemophilia. 1996 Apr;2(2):100-3. doi: 10.1111/j.1365-2516.1996.tb00023.x.

PMID:
27214016
13.

Anaphylaxis after treatment with recombinant factor VIII.

Shopnick RI, Kazemi M, Brettler DB, Buckwalter C, Yang L, Bray G, Gomperts ED.

Transfusion. 1996 Apr;36(4):358-61.

PMID:
8623140
14.

The knowledge and perception of factor concentrate in persons with haemophilia A.

Bolivar EP, Shopnick RI, Mannucci PM, Gringeri A, Brettler DB.

Haemophilia. 1995 Oct;1(4):232-5. doi: 10.1111/j.1365-2516.1995.tb00081.x.

PMID:
27214629
15.

Hepatitis C virus transmission by monoclonal purified viral-attenuated factor VIII concentrate.

Shopnick RI, Brettler DB, Bolivar E.

Lancet. 1995 Sep 2;346(8975):645. No abstract available.

PMID:
7651038
16.

Recombinant coagulation factor products.

Brettler DB.

Haemophilia. 1995 Jul;1(3):155-8. doi: 10.1111/j.1365-2516.1995.tb00059.x.

PMID:
27214531
17.

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC.

N Engl J Med. 1995 Jan 26;332(4):228-32. No abstract available.

18.

Inhibitors of factor VIII and IX.

Brettler DB.

Haemophilia. 1995 Jan;1 Suppl 1:35-9. doi: 10.1111/j.1365-2516.1995.tb00108.x. No abstract available.

PMID:
27214738
19.

Editorial.

Lee CA, Brettler DB.

Haemophilia. 1995 Jan;1(1):1. doi: 10.1111/j.1365-2516.1995.tb00031.x. No abstract available.

PMID:
27214213
20.

Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection.

Greenough TC, Somasundaran M, Brettler DB, Hesselton RM, Alimenti A, Kirchhoff F, Panicali D, Sullivan JL.

AIDS Res Hum Retroviruses. 1994 Apr;10(4):395-403.

PMID:
8068417
21.

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.

Mannucci PM, Brettler DB, Aledort LM, Lusher JM, Abildgaard CF, Schwartz RS, Hurst D.

Blood. 1994 Apr 1;83(7):1958-62.

22.

Comprehensive hemophilia care and home factor infusions.

Brettler DB.

Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:41-2. No abstract available.

PMID:
7886603
23.

Inhibitors of factor VIII: detection and treatment.

Brettler DB.

Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:21-5. Review.

PMID:
7886576
24.

Silent human immunodeficiency virus type 1 infection: a rare occurrence in a high-risk heterosexual population.

Brettler DB, Somasundaran M, Forsberg AF, Krause E, Sullivan JL.

Blood. 1992 Nov 1;80(9):2396-400.

25.

The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study.

Brettler DB, Mannucci PM, Gringeri A, Rasko JE, Forsberg AD, Rumi MG, Garsia RJ, Rickard KA, Colombo M.

Blood. 1992 Jul 15;80(2):540-3.

26.

Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo.

Bauer KA, Mannucci PM, Gringeri A, Tradati F, Barzegar S, Kass BL, ten Cate H, Kestin AS, Brettler DB, Rosenberg RD.

Blood. 1992 Apr 15;79(8):2039-47.

27.

Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group.

Mannucci PM, Schimpf K, Abe T, Aledort LM, Anderle K, Brettler DB, Hilgartner MW, Kernoff PB, Kunschak M, McMillan CW, et al.

Transfusion. 1992 Feb;32(2):134-8.

PMID:
1311876
28.

Hemophilia in the 1990s: principles of management and improved access to care.

Kasper CK, Mannucci PM, Bulyzhenkov V, Brettler DB, Chuansumrit A, Heijnen L, Isarankura P, Kernoff PB, Peake I, Rickard KA, et al.

Semin Thromb Hemost. 1992 Jan;18(1):1-10. Review. No abstract available.

PMID:
1574710
30.

Pregnancy in a cohort of long-term partners of human immunodeficiency virus-seropositive hemophiliacs.

Kraus EM, Brettler DB, Forsberg AD, Sullivan JL.

Obstet Gynecol. 1991 Nov;78(5 Pt 1):735-8.

PMID:
1923188
31.

Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.

Luzuriaga K, Koup RA, Pikora CA, Brettler DB, Sullivan JL.

J Pediatr. 1991 Aug;119(2):230-6.

PMID:
1907319
32.

Hepatocellular carcinoma in hemophilia.

Colombo M, Mannucci PM, Brettler DB, Girolami A, Lian EC, Rodeghiero F, Scharrer I, Smith PS, White GC 2nd.

Am J Hematol. 1991 Aug;37(4):243-6.

PMID:
1650134
33.

Comments on the development of inhibitor antibodies in patients using recombinant factor VIII concentrates.

Brettler DB.

Semin Hematol. 1991 Apr;28(2 Suppl 1):45-6. No abstract available.

PMID:
1908128
34.

Haemophilia in the 1990s: report of a joint meeting of the World Health Organization and World Federation of Hemophilia.

Kasper CK, Mannucci PM, Bulyzhenkov V, Brettler DB, Chuansumrit A, Heijnen L, Isarankura P, Kernoff PB, Peake I, Rickard KA, et al.

Vox Sang. 1991;61(3):221-4. No abstract available.

PMID:
1807066
35.

Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group.

Schwartz RS, Abildgaard CF, Aledort LM, Arkin S, Bloom AL, Brackmann HH, Brettler DB, Fukui H, Hilgartner MW, Inwood MJ, et al.

N Engl J Med. 1990 Dec 27;323(26):1800-5.

36.

Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia.

Brettler DB, Forsberg A, Bolivar E, Brewster F, Sullivan J.

J Pediatr. 1990 Oct;117(4):584-8. No abstract available.

PMID:
2213383
37.

Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients.

Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH.

Blood. 1990 Jul 1;76(1):254-6.

38.

Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.

Mannucci PM, Schimpf K, Brettler DB, Ciavarella N, Colombo M, Haschke F, Lechner K, Lusher J, Weissbach G.

Ann Intern Med. 1990 Jul 1;113(1):27-32.

PMID:
2112352
39.
40.

Factor concentrates for treatment of hemophilia: which one to choose?

Brettler DB, Levine PH.

Blood. 1989 Jun;73(8):2067-73. Review. No abstract available.

41.

The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience.

Brettler DB, Forsberg AD, Levine PH, Aledort LM, Hilgartner MW, Kasper CK, Lusher JM, McMillan C, Roberts H.

Arch Intern Med. 1989 Jun;149(6):1381-5.

PMID:
2499293
42.

Factor VIII:C concentrate purified from plasma using monoclonal antibodies: human studies.

Brettler DB, Forsberg AD, Levine PH, Petillo J, Lamon K, Sullivan JL.

Blood. 1989 May 15;73(7):1859-63.

43.

Assessment of reproductive risks and intentions by mothers of children with hemophilia.

Kraus EM, Brettler DB.

Am J Med Genet. 1988 Oct;31(2):259-67.

PMID:
3232693
44.

Human immunodeficiency virus isolation studies and antibody testing. Household contacts and sexual partners of persons with hemophilia.

Brettler DB, Forsberg AD, Levine PH, Andrews CA, Baker S, Sullivan JL.

Arch Intern Med. 1988 Jun;148(6):1299-301.

PMID:
3288158
45.

Primary pulmonary hypertension in patients with classic hemophilia.

Goldsmith GH Jr, Baily RG, Brettler DB, Davidson WR Jr, Ballard JO, Driscol TE, Greenberg JM, Kasper CK, Levine PH, Ratnoff OD.

Ann Intern Med. 1988 Jun;108(6):797-9.

PMID:
3130767
46.

Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities.

Andrews CA, Sullivan JL, Brettler DB, Brewster FE, Forsberg AD, Scesney S, Levine PH.

J Pediatr. 1987 Nov;111(5):672-7.

PMID:
2959763
47.

Immunologic aberrations, HIV seropositivity and seroconversion rates in patients with hemophilia B.

Brettler DB, Brewster F, Levine PH, Forsberg A, Baker S, Sullivan JL.

Blood. 1987 Jul;70(1):276-81.

48.

Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate.

Brettler DB, Forsberg AD, Brewster F, Sullivan JL, Levine PH.

Am J Med. 1986 Oct;81(4):607-11.

PMID:
2945433
49.

Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses.

Sullivan JL, Brewster FE, Brettler DB, Forsberg AD, Cheeseman SH, Byron KS, Baker SM, Willitts DL, Lew RA, Levine PH.

J Pediatr. 1986 Apr;108(4):504-10. Erratum in: J Pediatr 1986 Dec;109(6):1075.

PMID:
3007715
50.

Epidemiology and clinical impact of hepatitis D virus (delta) infection.

Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK.

Hepatology. 1985 Mar-Apr;5(2):188-91.

PMID:
3979950

Supplemental Content

Loading ...
Support Center